1092460-02-0

Basic information

• Product Name: (-)-1-[(4-chlorophenyl)phenylmethyl]-4-[(4-chlorophenyl)sulfonyl]piperazine
• CAS NO: 1092460-02-0
• Molecular Weight: 461.412
• Mol File: 1092460-02-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (-)-1-[(4-chlorophenyl)phenylmethyl]-4-[(4-chlorophenyl)sulfonyl]piperazine(CAS DataBase Reference)
• NIST Chemistry Reference: (-)-1-[(4-chlorophenyl)phenylmethyl]-4-[(4-chlorophenyl)sulfonyl]piperazine(1092460-02-0)
• EPA Substance Registry System: (-)-1-[(4-chlorophenyl)phenylmethyl]-4-[(4-chlorophenyl)sulfonyl]piperazine(1092460-02-0)

Safety Data

• Hazardous Substances Data: 1092460-02-0(Hazardous Substances Data)

Upstream product

• 6472-49-7 4-chloro-benzenesulfonic acid-[bis-(2-chloro-ethyl)-amide] 
• 163837-57-8 (R)-(4-chlorophenyl)(phenyl)methylamine 

Relevant articles and documents

PROCESS FOR PREPARATION OF SUBSTANTIALLY OPTICALLY PURE LEVOROTATORY AND DEXTROROTATORY ENANTIOMERS OF CETIRIZINE USING NOVEL INTERMEDIATES

The present invention relates to a novel and commercially viable process for substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine intermediate, 1-[(4-chlorophenyl)phenylmethyl]piperazine, thereby producing substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine and their pharmaceutical acceptable acid addition salts thereof in high purity and in high yield using novel intermediates.